SRC and cancer: With respect to this, the identification of this new Golgi-derived signalling network based on the Src-Aurora-A axis that controls pre-mitotic (G2/M transition) and post-mitotic51 events highlights the importance of new therapeutic strategies aimed at targeting both these proteins in cancer cells.